Volume 18, Issue 4 pp. 637-640
Short Paper
Full Access

Functional evidence that intercellular adhesion molecule-1 (icam-1) is a ligand for lfa-1d-ependent adhesion in t cell-mediated cytotoxicity

M. William Makgoba

Corresponding Author

M. William Makgoba

Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda

Department of Chemical Pathology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London, W120HS, GBSearch for more papers by this author
Martin E. Sanders

Martin E. Sanders

Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda

Search for more papers by this author
Gale E. Ginther Luce

Gale E. Ginther Luce

Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda

Search for more papers by this author
Ellen A. Gugel

Ellen A. Gugel

Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda

Search for more papers by this author
Michael L. Dustin

Michael L. Dustin

National Institutes of Health, Bethesda

Search for more papers by this author
Timothy A. Springer

Timothy A. Springer

Department of Membrane Immunochemistry, Dana-Farber Cancer InstituteA, Boston

Search for more papers by this author
Stephen Shaw

Stephen Shaw

Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda

Search for more papers by this author
First published: April 1988
Citations: 246

Abstract

Although intercellular adhesion molecule-1 (ICAM-1) has been implicated as a ligand in some LFA-1-dependent adhesion, its importance to T cell function has not been established. The present studies investigate the importance of ICAM-1 for human cytotoxic T lymphocytes (CTL), both in their formation of antigen-independent conjugates (AIC) and in their lysis of targets. Analysis of monoclonal antibody (mAb) inhibition of AIC formation indicate that ICAM-1 mAb 1 blocks (a) AIC formation with some but not all targets; (b)the LFA-1 pathway but not the CD2LFA-3 pathway of adhesion; (c) by binding to the target cell, not the T cell. In studies of cell-mediated lysis (CML) ICAM-1 mAb inhibited lysis of some targets, such as U-937, that use ICAM-1 predominantly in AIC formation; CML on some other targets is not inhibited by ICAM-1 mAb. These data indicate that ICAM-1 is a ligand for AIC formation, antigen-specific CTL recognition and cytolysis of particular target cells. The data also indicate that ICAM-1 is not used in LFA-1-dependent CTL interactions with all kinds of target cells, suggesting the existence of alternative ligands for LFA-1.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.